Published in PLoS Med on April 26, 2005
Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PLoS Med (2005) 8.36
Measuring malaria endemicity from intense to interrupted transmission. Lancet Infect Dis (2008) 6.53
Operational strategies to achieve and maintain malaria elimination. Lancet (2010) 6.48
Revisiting the basic reproductive number for malaria and its implications for malaria control. PLoS Biol (2007) 5.40
Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev (2011) 5.15
Targeting asymptomatic malaria infections: active surveillance in control and elimination. PLoS Med (2013) 3.23
Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria. Antimicrob Agents Chemother (2006) 3.10
Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity. PLoS Med (2008) 2.78
Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda. PLoS Clin Trials (2006) 2.72
Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials. Malar J (2008) 2.68
The complexities of malaria disease manifestations with a focus on asymptomatic malaria. Malar J (2012) 2.37
Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. PLoS One (2007) 2.17
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals. Antimicrob Agents Chemother (2010) 2.15
The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum. Malar J (2009) 2.03
A specific inhibitor of PfCDPK4 blocks malaria transmission: chemical-genetic validation. J Infect Dis (2013) 1.71
Chloroquine/sulphadoxine-pyrimethamine for gambian children with malaria: transmission to mosquitoes of multidrug-resistant Plasmodium falciparum. PLoS Clin Trials (2006) 1.69
Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity. Malar J (2008) 1.69
Malaria gametocytogenesis. Mol Biochem Parasitol (2010) 1.68
Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial. PLoS One (2009) 1.68
Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria. Antimicrob Agents Chemother (2008) 1.65
Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum. PLoS Clin Trials (2006) 1.63
Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria? Malar J (2010) 1.59
Mosquito feeding assays to determine the infectiousness of naturally infected Plasmodium falciparum gametocyte carriers. PLoS One (2012) 1.57
Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination. Malar J (2013) 1.57
The clinical efficacy of artemether/lumefantrine (Coartem). Malar J (2009) 1.52
Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence. J Infect Dis (2013) 1.52
Possible interruption of malaria transmission, highland Kenya, 2007-2008. Emerg Infect Dis (2009) 1.44
Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use. PLoS One (2007) 1.44
Identification of inhibitors of Plasmodium falciparum gametocyte development. Malar J (2013) 1.43
A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in Tanzania. Malar J (2011) 1.42
Randomised trial of chloroquine/sulphadoxine-pyrimethamine in Gambian children with malaria: impact against multidrug-resistant P. falciparum. PLoS Clin Trials (2006) 1.39
The spiroindolone drug candidate NITD609 potently inhibits gametocytogenesis and blocks Plasmodium falciparum transmission to anopheles mosquito vector. Antimicrob Agents Chemother (2012) 1.35
Reduced risk of malaria parasitemia following household screening and treatment: a cross-sectional and longitudinal cohort study. PLoS One (2012) 1.32
Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso. PLoS One (2008) 1.22
Malaria prevalence, spatial clustering and risk factors in a low endemic area of Eastern Rwanda: a cross sectional study. PLoS One (2013) 1.18
Plasmodium falciparum antigens on the surface of the gametocyte-infected erythrocyte. PLoS One (2008) 1.16
Novel strategies lead to pre-elimination of malaria in previously high-risk areas in Suriname, South America. Malar J (2012) 1.14
Does the drug sensitivity of malaria parasites depend on their virulence? Malar J (2008) 1.11
Ivermectin inhibits the sporogony of Plasmodium falciparum in Anopheles gambiae. Malar J (2012) 1.10
Routine delivery of artemisinin-based combination treatment at fixed health facilities reduces malaria prevalence in Tanzania: an observational study. Malar J (2012) 1.10
Safety profile of Coartem: the evidence base. Malar J (2009) 1.09
Gametocyte clearance in uncomplicated and severe Plasmodium falciparum malaria after artesunate-mefloquine treatment in Thailand. Korean J Parasitol (2008) 1.08
Screening of traditionally used plants for in vivo antimalarial activity in mice. Afr J Tradit Complement Altern Med (2009) 1.06
Ongoing challenges in the management of malaria. Malar J (2009) 1.03
Five years of large-scale dhfr and dhps mutation surveillance following the phased implementation of artesunate plus sulfadoxine-pyrimethamine in Maputo Province, Southern Mozambique. Am J Trop Med Hyg (2010) 1.03
Modeling within-host effects of drugs on Plasmodium falciparum transmission and prospects for malaria elimination. PLoS Comput Biol (2014) 1.01
Human immune responses that reduce the transmission of Plasmodium falciparum in African populations. Int J Parasitol (2010) 1.01
Monitoring, characterization and control of chronic, symptomatic malaria infections in rural Zambia through monthly household visits by paid community health workers. Malar J (2014) 1.01
High prevalence of asymptomatic malaria in a tribal population in eastern India. J Clin Microbiol (2013) 1.01
Re-engineering aryl methylcarbamates to confer high selectivity for inhibition of Anopheles gambiae versus human acetylcholinesterase. Bioorg Med Chem Lett (2012) 1.00
Transmission blocking activity of a standardized neem (Azadirachta indica) seed extract on the rodent malaria parasite Plasmodium berghei in its vector Anopheles stephensi. Malar J (2010) 0.96
The benefits of artemisinin combination therapy for malaria extend beyond the individual patient. PLoS Med (2005) 0.96
Rolling back a malaria epidemic in South Africa. PLoS Med (2005) 0.96
A simple, high-throughput, colourimetric, field applicable loop-mediated isothermal amplification (HtLAMP) assay for malaria elimination. Malar J (2015) 0.95
Blocking malaria transmission to Anopheles mosquitoes using artemisinin derivatives and primaquine: a systematic review and meta-analysis. Parasit Vectors (2013) 0.95
Rational deployment of antimalarial drugs in Africa: should first-line combination drugs be reserved for paediatric malaria cases? Parasitology (2011) 0.94
Update on the efficacy, effectiveness and safety of artemether-lumefantrine combination therapy for treatment of uncomplicated malaria. Ther Clin Risk Manag (2010) 0.93
Imaging-based high-throughput screening assay to identify new molecules with transmission-blocking potential against Plasmodium falciparum female gamete formation. Antimicrob Agents Chemother (2015) 0.91
A review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmission. Malar J (2014) 0.89
Artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria. Ther Clin Risk Manag (2009) 0.88
Lead clinical and preclinical antimalarial drugs can significantly reduce sporozoite transmission to vertebrate populations. Antimicrob Agents Chemother (2014) 0.88
Chloroquine Resistant Plasmodium falciparum in Nigeria: Relationship between pfcrt and pfmdr1 Polymorphisms, In-Vitro Resistance and Treatment Outcome. Open Trop Med J (2008) 0.88
The effects of ACT treatment and TS prophylaxis on Plasmodium falciparum gametocytemia in a cohort of young Ugandan children. Am J Trop Med Hyg (2013) 0.84
Comparing highly efficacious antimalarial drugs. PLoS Med (2008) 0.84
Exploration of in vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in under fives in Tabora region, Tanzania. Malar J (2013) 0.84
Application of pharmacogenomics to malaria: a holistic approach for successful chemotherapy. Pharmacogenomics (2009) 0.83
Artemisinin-based combination therapy does not measurably reduce human infectiousness to vectors in a setting of intense malaria transmission. Malar J (2012) 0.83
Subtle changes in Plasmodium falciparum infection complexity following enhanced intervention in Malawi. Acta Trop (2014) 0.82
HIV-positive nigerian adults harbor significantly higher serum lumefantrine levels than HIV-negative individuals seven days after treatment for Plasmodium falciparum infection. Antimicrob Agents Chemother (2013) 0.82
Malaria management-progress made and challenges still to face. Malar J (2009) 0.82
Strategic use of antimalarial drugs that block falciparum malaria parasite transmission to mosquitoes to achieve local malaria elimination. Parasitol Res (2014) 0.81
Efficacy of amodiaquine in the treatment of uncomplicated falciparum malaria in young children of rural north-western Burkina Faso. Malar J (2008) 0.81
Transmission and cross-mating of high-level resistance Plasmodium falciparum dihydrofolate reductase haplotypes in The Gambia. Am J Trop Med Hyg (2010) 0.80
Investigating preferences for mosquito-control technologies in Mozambique with latent class analysis. Malar J (2011) 0.77
Antimalarial iron chelator FBS0701 blocks transmission by Plasmodium falciparum gametocyte activation inhibition. Antimicrob Agents Chemother (2014) 0.77
Analyzing Thiol-Dependent Redox Networks in the Presence of Methylene Blue and Other Antimalarial Agents with RT-PCR-Supported in silico Modeling. Bioinform Biol Insights (2012) 0.75
Multi-year optimization of malaria intervention: a mathematical model. Malar J (2016) 0.75
[Asymptomatic Parasitemia in under five, school age children and households self-medication, Lubumbashi, Democratic Republic of Congo]. Pan Afr Med J (2016) 0.75
Disparities between malaria infection and treatment rates: Evidence from a cross-sectional analysis of households in Uganda. PLoS One (2017) 0.75
Primaquine plus artemisinin combination therapy for reduction of malaria transmission: promise and risk. BMC Med (2016) 0.75
Life-span of in vitro differentiated Plasmodium falciparum gametocytes. Malar J (2017) 0.75
Additional burden of asymptomatic and sub-patent malaria infections during low transmission season in forested tribal villages in Chhattisgarh, India. Malar J (2017) 0.75
Averting a malaria disaster. Lancet (1999) 9.40
Effects of artemisinin derivatives on malaria transmissibility. Lancet (1996) 7.42
Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria. Antimicrob Agents Chemother (2000) 4.77
Antifolate antimalarial resistance in southeast Africa: a population-based analysis. Lancet (2003) 4.26
Comparison of two simple methods for determining malaria parasite density. Trans R Soc Trop Med Hyg (1991) 3.94
Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp. Am J Trop Med Hyg (2003) 3.71
Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. J Infect Dis (2001) 3.36
Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria. Am J Trop Med Hyg (1999) 2.98
The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy. Trop Med Int Health (2003) 2.94
Risk factors for gametocyte carriage in uncomplicated falciparum malaria. Am J Trop Med Hyg (1999) 2.94
Generalized linear modelling for parasitologists. Parasitol Today (1997) 2.47
Gambian children successfully treated with chloroquine can harbor and transmit Plasmodium falciparum gametocytes carrying resistance genes. Am J Trop Med Hyg (2002) 2.25
Meningococcal carriage in a population of "normal" families. J Infect Dis (1971) 2.15
Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years. Trop Med Int Health (1998) 2.10
Plasmodium falciparum gametocytes: their longevity and infectivity. Parasitology (1977) 2.02
Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short-lived reduction in infectiousness for mosquitoes. Trop Med Int Health (2004) 1.93
Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet (2000) 1.90
A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children. Am J Trop Med Hyg (1998) 1.72
Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes. Antimicrob Agents Chemother (2004) 1.71
The safety and efficacy of sulfadoxine-pyrimethamine, amodiaquine, and their combination in the treatment of uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg (2002) 1.60
The addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children delays, but does not prevent treatment failure. Am J Trop Med Hyg (2003) 1.41
New antimalarial treatment for KwaZulu-Natal. S Afr Med J (2001) 1.17
Pharmacokinetics of sequential and simultaneous treatment with the combination chloroquine and sulfadoxine-pyrimethamine in acute uncomplicated Plasmodium falciparum malaria in the Philippines. Trop Med Int Health (2002) 1.16
Genetic complexity of Plasmodium falciparum gametocytes isolated from the peripheral blood of treated Gambian children. Am J Trop Med Hyg (2002) 1.15
Treatment uptake by individuals infected with Plasmodium falciparum in rural Gambia, West Africa. Bull World Health Organ (2002) 1.11
Plasmodium falciparum gametocytes in Gambian adults. Ann Trop Med Parasitol (2000) 1.07
The biology of Plasmodium falciparum transmission stages. Parasitology (1998) 0.99
Antipyretic, parasitologic, and immunologic effects of combining sulfadoxine/pyrimethamine with chloroquine or paracetamol for treating uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg (2003) 0.89
Eimeria stiedai in rabbits: the presence of an oocyst residuum. Parasitology (1977) 0.85
Malaria. Lancet (2005) 7.37
Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet (2009) 4.30
Increased proportions of outdoor feeding among residual malaria vector populations following increased use of insecticide-treated nets in rural Tanzania. Malar J (2011) 4.27
Role of flies and provision of latrines in trachoma control: cluster-randomised controlled trial. Lancet (2004) 3.69
Effect of two different house screening interventions on exposure to malaria vectors and on anaemia in children in The Gambia: a randomised controlled trial. Lancet (2009) 3.45
Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria. PLoS Med (2009) 3.38
Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. J Infect Dis (2006) 3.17
A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease. Nat Med (2004) 2.93
The epidemiology of Plasmodium falciparum gametocytes: weapons of mass dispersion. Trends Parasitol (2006) 2.53
Standardized data collection for multi-center clinical studies of severe malaria in African children: establishing the SMAC network. Trans R Soc Trop Med Hyg (2006) 2.52
Gambian children successfully treated with chloroquine can harbor and transmit Plasmodium falciparum gametocytes carrying resistance genes. Am J Trop Med Hyg (2002) 2.25
Culturally compelling strategies for behaviour change: a social ecology model and case study in malaria prevention. Soc Sci Med (2005) 2.25
Effect on the incidence of pneumonia of vitamin D supplementation by quarterly bolus dose to infants in Kabul: a randomised controlled superiority trial. Lancet (2012) 2.21
Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific. Infect Immun (2008) 2.18
High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581. PLoS One (2009) 2.18
Insecticide-treated bednets to control dengue vectors: preliminary evidence from a controlled trial in Haiti. Trop Med Int Health (2008) 1.96
Allelic heterogeneity of G6PD deficiency in West Africa and severe malaria susceptibility. Eur J Hum Genet (2009) 1.94
Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short-lived reduction in infectiousness for mosquitoes. Trop Med Int Health (2004) 1.93
Determination of the processes driving the acquisition of immunity to malaria using a mathematical transmission model. PLoS Comput Biol (2007) 1.87
Target antigen, age, and duration of antigen exposure independently regulate immunoglobulin G subclass switching in malaria. Infect Immun (2006) 1.87
Erythrocyte invasion phenotypes of Plasmodium falciparum in The Gambia. Infect Immun (2003) 1.85
Unique regulation of adipose triglyceride lipase (ATGL) by perilipin 5, a lipid droplet-associated protein. J Biol Chem (2011) 1.83
Social contact patterns in Vietnam and implications for the control of infectious diseases. PLoS One (2011) 1.83
Anopheles gambiae complex along The Gambia river, with particular reference to the molecular forms of An. gambiae s.s. Malar J (2008) 1.76
High spatial resolution mapping of malaria transmission risk in the Gambia, west Africa, using LANDSAT TM satellite imagery. Am J Trop Med Hyg (2007) 1.74
Common variation in the ABO glycosyltransferase is associated with susceptibility to severe Plasmodium falciparum malaria. Hum Mol Genet (2007) 1.72
Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes. Antimicrob Agents Chemother (2004) 1.71
A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults. PLoS Med (2004) 1.70
The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia. Trans R Soc Trop Med Hyg (2003) 1.69
Contrasting patterns in the small-scale heterogeneity of human helminth infections in urban and rural environments in Brazil. Int J Parasitol (2006) 1.69
Chloroquine/sulphadoxine-pyrimethamine for gambian children with malaria: transmission to mosquitoes of multidrug-resistant Plasmodium falciparum. PLoS Clin Trials (2006) 1.69
Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum. PLoS Clin Trials (2006) 1.63
Seroprevalence and risk factors for dengue infection in socio-economically distinct areas of Recife, Brazil. Acta Trop (2009) 1.61
Seasonal carriage of pfcrt and pfmdr1 alleles in Gambian Plasmodium falciparum imply reduced fitness of chloroquine-resistant parasites. J Infect Dis (2007) 1.58
Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian men. J Infect Dis (2004) 1.58
Haplotypic analysis of the TNF locus by association efficiency and entropy. Genome Biol (2003) 1.55
Modelling of malaria temporal variations in Iran. Trop Med Int Health (2008) 1.51
Positive selection of a CD36 nonsense variant in sub-Saharan Africa, but no association with severe malaria phenotypes. Hum Mol Genet (2009) 1.50
Design of the leprosy component of the Brazilian BCG revaccination trial for assessing BCG effectiveness against leprosy in school children. Int J Lepr Other Mycobact Dis (2004) 1.48
Carriage of chloroquine-resistant parasites and delay of effective treatment increase the risk of severe malaria in Gambian children. J Infect Dis (2005) 1.47
Protective efficacy of the RTS,S/AS02 Plasmodium falciparum malaria vaccine is not strain specific. Am J Trop Med Hyg (2003) 1.45
Incidence and risk factors of paediatric rotavirus diarrhoea in northern Ghana. Trop Med Int Health (2003) 1.42
The addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children delays, but does not prevent treatment failure. Am J Trop Med Hyg (2003) 1.41
Declining incidence of malaria imported into the UK from West Africa. Malar J (2008) 1.39
Randomised trial of chloroquine/sulphadoxine-pyrimethamine in Gambian children with malaria: impact against multidrug-resistant P. falciparum. PLoS Clin Trials (2006) 1.39
Attractiveness of MM-X traps baited with human or synthetic odor to mosquitoes (Diptera: Culicidae) in The Gambia. J Med Entomol (2007) 1.37
Presumptive treatment of fever cases as malaria: help or hindrance for malaria control? Malar J (2008) 1.36
How is childhood development of immunity to Plasmodium falciparum enhanced by certain antimalarial interventions? Malar J (2007) 1.35
Safety and immunogenicty of RTS,S/AS02A candidate malaria vaccine in Gambian children. Vaccine (2005) 1.35
Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul: a randomised controlled trial. Trop Med Int Health (2010) 1.34
Risk factors for and clinical outcome of congenital cytomegalovirus infection in a peri-urban West-African birth cohort. PLoS One (2007) 1.33
Airflow attenuation and bed net utilization: observations from Africa and Asia. Malar J (2012) 1.32
Is mosquito larval source management appropriate for reducing malaria in areas of extensive flooding in The Gambia? A cross-over intervention trial. Am J Trop Med Hyg (2010) 1.29
The "far-west" of Anopheles gambiae molecular forms. PLoS One (2011) 1.28
High gametocyte complexity and mosquito infectivity of Plasmodium falciparum in the Gambia. Int J Parasitol (2007) 1.25
Imputation-based meta-analysis of severe malaria in three African populations. PLoS Genet (2013) 1.25